N@N

Market Maker Surveillance Report. MDGN, TELK, JRCC, ATPG, MDW, OMER, Losing Stocks With Lowest Price Friction For Tuesday, Jun

June 26, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3802 companies with "abnormal" market making, 2713 companies with positive Friction Factors and 2659 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. MEDGENICS INC - UNRESTRICTED (OTCBB:MDGN), TELIK INC (NASDAQ:TELK), JAMES RIVER COAL CO (NASDAQ:JRCC), ATP OIL & GAS CORPORATION (NASDAQ:ATPG), MIDWAY GOLD CORP (AMEX:MDW), OMEROS CORP (NASDAQ:OMER). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  MDGN    $-1.400   -11.78%   71,036       33.12%    87,445       40.77%    -16,409      -117    
  TELK    $-0.600   -20.27%   537,234      49.57%    540,520      49.88%    -3,286       -55     
  JRCC    $-0.440   -15.07%   1,659,950    46.98%    1,868,092    52.87%    -208,142     -4,731  
  ATPG    $-0.460   -13.49%   2,521,227    44.66%    3,123,839    55.34%    -602,612     -13,100 
  MDW     $-0.170   -12.23%   172,569      23.86%    242,469      33.53%    -69,900      -4,112  
  OMER    $-2.470   -18.66%   46,371       43.57%    59,463       55.87%    -13,092      -53     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MDGN with a dollar loss Tuesday of $-1.40000 and a Friction Factor of -117 shares. That means that it only took 117 more shares of selling than buying to move MDGN lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

MEDGENICS INC - UNRESTRICTED (OTCBB:MDGN) - Medgenics, Inc., a biopharmaceutical company, through its subsidiary Medgenics Medical Israel Ltd., engages in the research and development of products in the field of biotechnology and associated medical equipment. Its Biopump platform technology allows patients to produce their natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C. The company develops EPODURE, a Phase I/II clinical trial product for the treatment of chronic renal anemia; and INFRADURE for the treatment of hepatitis C. It also develops a pipeline of products based on its Biopump technology, such as clotting Factor VIII for the treatment of hemophilia. The companys platform technology also has the potential to treat a range of other therapeutic areas, such as multiple sclerosis, pediatric growth hormone deficiency/muscular atrophy, diabetes, arthritis, wound healing, obesity, chronic pain, and cancer recovery. Medgenics, Inc. was founded in 2000 and is based in Vienna, Virginia.

TELIK INC (NASDAQ:TELK) - Telik, Inc., a clinical stage drug development company, focuses on discovering and developing small molecule drugs to treat cancer. The companys advanced investigational drug candidates in clinical development are TELINTRA, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy; and TELCYTA, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Its preclinical drug product candidates for the treatment of cancer comprise TLK60404, a small molecule compound inhibiting Aurora kinase and VEGFR kinase; and TLK60596, a small-molecule dual inhibitor of VEGFR1 and VEGFR2 kinase. Telik's product candidates are discovered using its proprietary drug discovery technology, TRAP that enables the rapid and efficient discovery of small molecule drug candidates. The company was founded in 1988 and is based in Palo Alto, California.

JAMES RIVER COAL CO (NASDAQ:JRCC) - James River Coal Company, through its subsidiaries, engages in mining, processing, and selling bituminous, steam- and industrial-grade coal in eastern Kentucky and southern Indiana. It conducts mining operations in Bell County, Bledsoe, Blue Diamond, Leeco, and Triad mining complexes. As of December 31, 2009, the company had 6 mining complexes, including 14 underground mines, 10 surface mines, and 10 preparation plants, as well as controlled approximately 271.1 million tons of proven and probable coal reserves in Central Appalachia and Midwest regions. It sells coal to electric utilities and industrial customers. The company was founded in 1988 and is headquartered in Richmond, Virginia.

ATP OIL & GAS CORPORATION (NASDAQ:ATPG) - ATP Oil & Gas Corporation engages in the acquisition, development, and production of oil and natural gas properties in the Gulf of Mexico, the United Kingdom, and the Dutch Sectors of the North Sea. As of December 31, 2009, it had estimated net proved reserves of approximately 135.2 million barrels of crude oil or other liquid hydrocarbons equivalent (MMBoe), of which approximately 91.3 MMboe were in the Gulf of Mexico and 43.9 MMBoe were in the North Sea. The company also owned leasehold and other interests in 62 offshore blocks and 104 wells, including 19 subsea wells in the Gulf of Mexico, as well as had interests in 11 blocks and 3 company-operated subsea wells in the North Sea. It had reserves of approximately 77.9 million barrels of crude oil or other liquid hydrocarbons and 343.3 billion cubic feet of natural gas. The company was founded in 1991 and is based in Houston, Texas.

MIDWAY GOLD CORP (AMEX:MDW) - Midway Gold Corp. engages in the acquisition, exploration, and development of gold and silver mineral properties in North America. It primarily explores the Midway, Spring Valley, and Pan gold and silver mineral properties located in Nevada; and the Golden Eagle gold mineral property located in Washington. The company was formerly known as Red Emerald Resource Corp. and changed its name to Midway Gold Corp. in July 2002. Midway Gold Corp. was founded in 1996 and is based in White Rock, Canada.

OMEROS CORP (NASDAQ:OMER) - Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The companys lead PharmacoSurgery product candidate, OMS103HP, is in Phase III clinical program for evaluating OMS103HPs safety and ability to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament; and to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. Its PharmacoSurgery product candidates also include OMS302, which completed its Phase I/II clinical trial for use during ophthalmological procedures; and OMS201, which is in Phase I/II clinical trial for use during urological surgery. The company also engages in developing proprietary compositions that include peroxisome proliferator-activated receptor gamma (PPARγ) agonists for the treatment and prevention of addiction to substances of abuse. Its pipeline of preclinical product development programs include MASP-2 program for developing proprietary mannan-binding lectin-associated serine protease-2 antibody therapies to treat disorders caused by complement-activated inflammation; PDE10 program for developing proprietary compounds to treat schizophrenia and other psychotic disorders; PDE7 program for developing proprietary compounds to treat movement disorders; and GPCR program for the de-orphanization of orphan G protein-coupled receptors. Omeros Corporation was founded in 1994 and is based in Seattle, Washington.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net